160 related articles for article (PubMed ID: 35597916)
1. Role of CDH23 as a prognostic biomarker and its relationship with immune infiltration in acute myeloid leukemia.
Yang J; Lu F; Ma G; Pang Y; Zhao Y; Sun T; Ma D; Ye J; Ji C
BMC Cancer; 2022 May; 22(1):568. PubMed ID: 35597916
[TBL] [Abstract][Full Text] [Related]
2. Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma.
Cao B; Guo X; Huang L; Wang B; Wang W; Han D; Zhang W; Zhong K
Aging (Albany NY); 2021 Jul; 13(13):17768-17788. PubMed ID: 34252883
[TBL] [Abstract][Full Text] [Related]
3. HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia.
Cheng F; Li Q; Wang J; Wang L; Li W; Zeng F
Dis Markers; 2022; 2022():3199589. PubMed ID: 35280440
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia.
Lin MS; Zhong HY; Yim RL; Chen QY; Du HL; He HQ; Lin K; Zhao P; Gao R; Gao F; Zhang MY
BMC Cancer; 2022 Oct; 22(1):1068. PubMed ID: 36243694
[TBL] [Abstract][Full Text] [Related]
5. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic implications and functional enrichment analysis of LTB4R in patients with acute myeloid leukemia].
Zhang X; Zhang X; Liu P; Liu K; Li W; Chen Q; Ma W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):309-320. PubMed ID: 35426793
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia.
Zhao Y; Zhang Y; Lu W; Sun R; Guo R; Cao X; Liu X; Lyu C; Zhao M
BMC Med Genomics; 2023 Nov; 16(1):296. PubMed ID: 37980495
[TBL] [Abstract][Full Text] [Related]
8. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and potential mechanism of heat shock factor 1 in acute myeloid leukemia.
Lyu C; Wang Q; Yin X; Li Z; Wang T; Wang Y; Cui S; Liu K; Wang Z; Gao C; Xu R
Aging (Albany NY); 2022 Sep; 14(17):7026-7037. PubMed ID: 36069792
[TBL] [Abstract][Full Text] [Related]
10. The KIR2DL family serves as prognostic biomarkers and correlates with immune infiltrates in acute myeloid leukaemia.
Liu W; Zhu M; Li G; Xi Y
J Cell Mol Med; 2024 Apr; 28(8):e18256. PubMed ID: 38527290
[TBL] [Abstract][Full Text] [Related]
11. DOK2 Has Prognostic and Immunologic Significance in Adults With Acute Myeloid Leukemia: A Novel Immune-Related Therapeutic Target.
Xu J; Dong X; Wang R; Chen B
Front Med (Lausanne); 2022; 9():842383. PubMed ID: 35321466
[TBL] [Abstract][Full Text] [Related]
12. N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia.
Zhang L; Ke W; Hu P; Li Z; Geng W; Guo Y; Song B; Jiang H; Zhang X; Wan C
Front Genet; 2022; 13():804614. PubMed ID: 35615374
[No Abstract] [Full Text] [Related]
13. SPINK2 is a prognostic biomarker related to immune infiltration in acute myeloid leukemia.
Chen X; Zhao L; Yu T; Zeng J; Chen M
Am J Transl Res; 2022; 14(1):197-210. PubMed ID: 35173838
[TBL] [Abstract][Full Text] [Related]
14. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
[TBL] [Abstract][Full Text] [Related]
15. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
16. The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia.
Su X; Ma G; Bai X; Zhang J; Li M; Zhang F; Sun T; Ma D; Lu F; Ji C
Front Cell Dev Biol; 2022; 10():978786. PubMed ID: 36313565
[TBL] [Abstract][Full Text] [Related]
17. Expression signature of ten small nuclear RNAs serves as novel biomarker for prognosis prediction of acute myeloid leukemia.
Zhang Z; Huang R; Lai Y
Sci Rep; 2023 Oct; 13(1):18489. PubMed ID: 37898705
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive pan-cancer analysis identifies the RNA-binding protein LRPPRC as a novel prognostic and immune biomarker.
Wu Z; Liu X; Xie F; Ma C; Lam EW; Kang N; Jin D; Yan J; Jin B
Life Sci; 2024 Apr; 343():122527. PubMed ID: 38417544
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics Analysis Identifies EPAS1 as a Novel Prognostic Marker Correlated with Immune Infiltration in Acute Myeloid Leukemia.
Wang S; Zhang P
Dis Markers; 2023; 2023():6072782. PubMed ID: 37124944
[TBL] [Abstract][Full Text] [Related]
20. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
Front Immunol; 2021; 12():695865. PubMed ID: 34135913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
